Johnny Roy

887 total citations
8 papers, 571 citations indexed

About

Johnny Roy is a scholar working on Endocrinology, Diabetes and Metabolism, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johnny Roy has authored 8 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Urology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johnny Roy's work include Hormonal and reproductive studies (6 papers), Urinary Bladder and Prostate Research (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Johnny Roy is often cited by papers focused on Hormonal and reproductive studies (6 papers), Urinary Bladder and Prostate Research (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Johnny Roy collaborates with scholars based in United States, Sweden and Norway. Johnny Roy's co-authors include Richard Conn, Steven G. Chrysant, Kathleen Ice, Jay Y. Gillenwater, Michael Gaffney, Joanne Waldstreicher, Alvin M. Matsumoto, JAIME BONILLA, Mark A. Bach and Patrick Walsh and has published in prestigious journals such as The Journal of Urology, European Urology and Urology.

In The Last Decade

Johnny Roy

8 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnny Roy United States 7 464 310 220 190 69 8 571
Weining Volinn United States 9 359 0.8× 142 0.5× 163 0.7× 163 0.9× 67 1.0× 15 423
Claus Roehrborn United States 13 425 0.9× 309 1.0× 110 0.5× 187 1.0× 39 0.6× 43 488
K J Hoefner United States 3 624 1.3× 461 1.5× 265 1.2× 275 1.4× 76 1.1× 4 737
Tania Hossack Australia 11 282 0.6× 320 1.0× 98 0.4× 177 0.9× 24 0.3× 21 530
M. Cemil Uygur Türkiye 13 267 0.6× 133 0.4× 98 0.4× 114 0.6× 28 0.4× 35 454
Allam Fakhoury United States 8 427 0.9× 116 0.4× 83 0.4× 321 1.7× 14 0.2× 10 453
Leanna Laor United States 4 220 0.5× 131 0.4× 87 0.4× 86 0.5× 18 0.3× 6 318
Daniele Urzì Italy 10 112 0.2× 98 0.3× 64 0.3× 52 0.3× 21 0.3× 17 266
Andrew Harbin United States 10 113 0.2× 88 0.3× 94 0.4× 33 0.2× 80 1.2× 23 301
P. A. Gammelgaard Denmark 9 50 0.1× 155 0.5× 23 0.1× 30 0.2× 9 0.1× 21 268

Countries citing papers authored by Johnny Roy

Since Specialization
Citations

This map shows the geographic impact of Johnny Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Roy more than expected).

Fields of papers citing papers by Johnny Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Roy. The network helps show where Johnny Roy may publish in the future.

Co-authorship network of co-authors of Johnny Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Johnny Roy. A scholar is included among the top collaborators of Johnny Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnny Roy. Johnny Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wessells, Hunter, Johnny Roy, John T. Grayhack, et al.. (2003). Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology. 61(3). 579–584. 104 indexed citations
2.
Roehrborn, Claus G., John D. McConnell, JAIME BONILLA, et al.. (2000). SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 163(1). 13–20. 195 indexed citations
3.
Overstreet, James W., Vivian L. Fuh, John E. Gould, et al.. (1999). CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN. The Journal of Urology. 1295–1300. 6 indexed citations
4.
Oesterling, Joseph E., Johnny Roy, Torben Krarup, et al.. (1998). Biologic Variability of Prostate-Specific Antigen and its Usefulness as a Marker for Prostate Cancer: Effects of Finasteride. Urology. 51(4). 58–63. 9 indexed citations
5.
Oesterling, Joseph E., Johnny Roy, Torben Krarup, et al.. (1997). Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasteride. Urology. 50(1). 13–18. 43 indexed citations
6.
Moore, E. Colleen, Bruce Bracken, William J. Bremner, et al.. (1995). Proscar®: Five-Year Experience. European Urology. 28(4). 304–309. 52 indexed citations
7.
Gillenwater, Jay Y., Richard Conn, Steven G. Chrysant, et al.. (1995). Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study. The Journal of Urology. 154(1). 110–115. 158 indexed citations
8.
Gillenwater, Jay Y., Richard Conn, Steven G. Chrysant, et al.. (1995). Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension. The Journal of Urology. 110–115. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026